These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 29730261

  • 21. pH-sensitive and tumor-targeting nanogels based on ortho ester-modified PEG for improving the in vivo anti-tumor efficiency of doxorubicin.
    Wang X, Zheng Y, Xue Y, Wu Y, Liu Y, Cheng X, Tang R.
    Colloids Surf B Biointerfaces; 2021 Nov; 207():112024. PubMed ID: 34384973
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Exogenous vitamin C triggered structural changes of redox-activated dual core-crosslinked biodegradable nanogels for boosting the antitumor efficiency.
    Zhu Y, He Y, Su T, Li C, Cai S, Wu Z, Huang D, Zhang X, Cao J, He B.
    J Mater Chem B; 2020 Jun 21; 8(23):5109-5116. PubMed ID: 32412025
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Smart pH/Redox Dual-Responsive Nanogels for On-Demand Intracellular Anticancer Drug Release.
    Yang H, Wang Q, Huang S, Xiao A, Li F, Gan L, Yang X.
    ACS Appl Mater Interfaces; 2016 Mar 21; 8(12):7729-38. PubMed ID: 26960600
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
    Lee JY, Chung SJ, Cho HJ, Kim DD.
    Eur J Pharm Biopharm; 2015 Aug 21; 94():532-41. PubMed ID: 26149228
    [Abstract] [Full Text] [Related]

  • 30. Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin.
    Du H, Liu M, Yu A, Ji J, Zhai G.
    Int J Pharm; 2017 May 15; 523(1):427-438. PubMed ID: 28359815
    [Abstract] [Full Text] [Related]

  • 31. Reductively degradable α-amino acid-based poly(ester amide)-graft-galactose copolymers: facile synthesis, self-assembly, and hepatoma-targeting doxorubicin delivery.
    Lv J, Sun H, Zou Y, Meng F, Dias AA, Hendriks M, Feijen J, Zhong Z.
    Biomater Sci; 2015 Jul 15; 3(7):1134-46. PubMed ID: 26221946
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Galactose-functionalized multi-responsive nanogels for hepatoma-targeted drug delivery.
    Lou S, Gao S, Wang W, Zhang M, Zhang J, Wang C, Li C, Kong D, Zhao Q.
    Nanoscale; 2015 Feb 21; 7(7):3137-46. PubMed ID: 25613320
    [Abstract] [Full Text] [Related]

  • 35. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
    Chen T, Xiao Y, Lu W, Liu S, Gan L, Yu J, Huang J.
    Colloids Surf B Biointerfaces; 2018 Jan 01; 161():606-613. PubMed ID: 29156337
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Hydrophobicity-Adaptive Nanogels for Programmed Anticancer Drug Delivery.
    Yang H, Wang Q, Li Z, Li F, Wu D, Fan M, Zheng A, Huang B, Gan L, Zhao Y, Yang X.
    Nano Lett; 2018 Dec 12; 18(12):7909-7918. PubMed ID: 30450914
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Biodegradable phosphorylcholine-based zwitterionic polymer nanogels with smart charge-conversion ability for efficient inhibition of tumor cells.
    Peng S, Men Y, Xie R, Tian Y, Yang W.
    J Colloid Interface Sci; 2019 Mar 15; 539():19-29. PubMed ID: 30572286
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.